12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

Simone Perna,1 Manuela Mainardi,2 Paolo Astrone,2 Carlotta Gozzer,3 Anna Biava,1 Ruben Bacchio,3 Daniele Spadaccini,3 Sebastiano Bruno Solerte,2 Mariangela Rondanelli4 1Department of Biology, College of Science, University of Bahrain, Sakhir Campus, Kingdom of Bahrain; 2University of Pavia, Departme...

Full description

Bibliographic Details
Main Authors: Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Clinical Pharmacology : Advances and Applications
Subjects:
SGLT-2 inhibitors
incretins
cognitive performance
cognitive impairment
metabolic outcome
Online Access:https://www.dovepress.com/12-month-effects-of-incretins-versus-sglt2-inhibitors-on-cognitive-per-peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/12-month-effects-of-incretins-versus-sglt2-inhibitors-on-cognitive-per-peer-reviewed-article-CPAA

Similar Items